Teva Pharmaceutical Industries has appointed Carlo De Notaristefani as president and ceo of Global Operations, and Aharon (Arik) Yaari as executive vice president of Community and Institutional Affairs, a newly created organisation.
Both men will report directly to Jeremy Levin, who became president and ceo earlier this year.
De Notaristefani will take responsibility for Teva’s product supply and its manufacturing network.
Most recently, De Notaristefani was at Bristol Myers Squibb (BMS) as president, Technical Operations and Global Support functions. Before joining BMS, he held several senior positions in manufacturing and supply chain at Aventis Pharmaceuticals.
Yaari will execute on Teva’s global commitment to social responsibility, philanthropy, institutional affairs and academic relations. He joined Teva in 1981, and has held key positions at the company, including group vice president, Global API, and most recently as group vice president, Teva Generics Systems. He has also held various marketing and sales positions.
